Position in VRTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$11,622,488
+$1,290,893 QoQ
Shares Held
23,398
+1.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#340
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. VRTX ranks #1 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
23,398 | $11,622,488 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,444 | $6,512,251 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,814 | $4,158,428 | |
| 4 | MRNA |
Moderna, Inc.
|
33,142 | $2,320,934 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
17,163 | $2,278,044 | |
| 6 | CYTK |
Cytokinetics Inc
|
25,572 | $2,178,478 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
5,770 | $2,144,535 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
18,455 | $2,116,234 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,622,488 | 23,398 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $10,331,595 | 23,137 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $13,064,928 | 28,818 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $10,337,337 | 26,395 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $12,177,555 | 27,353 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $11,960,994 | 24,671 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $11,506,749 | 28,574 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,985,033 | 27,920 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,848,801 | 29,546 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $11,015,399 | 26,352 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $11,426,284 | 28,082 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,549,883 | 24,587 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,014,973 | 19,934 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,975,932 | 18,967 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,916,795 | 41,266 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $11,953,369 | 41,284 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $12,202,070 | 43,302 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $12,813,105 | 49,098 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $12,870,316 | 58,608 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $12,193,035 | 67,220 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,546,108 | 67,183 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $14,911,002 | 69,389 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $16,869,712 | 71,379 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $18,000,465 | 66,149 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $21,671,641 | 74,650 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $15,435,102 | 64,867 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||